Literature DB >> 25392323

How safe is natalizumab during pregnancy?

Pierre Duquette1, Alexandre Prat2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25392323     DOI： 10.1177/1352458514555789

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  3 in total

Review 1.  Management of women with multiple sclerosis through pregnancy and after childbirth.

Authors:  Patricia K Coyle
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

2.  Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy.

Authors:  Elisabetta Godano; Fabio Barra; Alessandra Allodi; Antonella Ferraiolo; Alice Laroni; Giovanni Novi; Giovanni Luigi Mancardi; Claudio Gustavino; Cesare Arioni
Journal:  Ital J Pediatr       Date:  2021-03-23       Impact factor: 2.638

3.  Disease activity following pregnancy-related discontinuation of natalizumab in MS.

Authors:  Iris Kleerekooper; Zoé L E van Kempen; Cyra E Leurs; Iris Dekker; Theo Rispens; Birgit I Lissenberg-Witte; Caspar E P van Munster; Brigit A de Jong; Bob W van Oosten; Bernard M J Uitdehaag; Mike P Wattjes; Joep Killestein
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.